# QNO: Neuromuscular Tongue Muscle Stimulator For The Reduction Of Snoring And Obstructive Sleep Apnea

- Device class: 2; regulation: 21 CFR 872.5575; FDA's rule: 510(k) required
- FDA decisions: 3
- 510(k) review time 2021–2025: median 83 days (middle half 73–92)
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2021: 1
- 2023: 1
- 2024: 1

## Most-cited predicates
- K223446: eXciteOSA without remote control (3000);  eXciteOSA with remote control (6000) (2023), cited by 1

Source page: https://510kreport.com/product-code/QNO
Data by year (CSV): https://510kreport.com/product-code/QNO.csv